CLINICAL_TRIALS
trial_result
· 2019-03-28
Clinical Trial Update: Cilostazol Stroke Prevention Study for Antiplatelet Combination [Phase 4]
Summary
A Phase 4 trial update on cilostazol for prevention of stroke when used in combination with antiplatelets in noncardioembolic cerebral infarction.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Japan Cardiovascular Research Foundation | Conditions: Noncardioembolic Cerebral Infarction | Phase 4 | Status: COMPLETED